Little Green Pharma (ASX:LGP) Net Cash per Share : A$-0.02 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Little Green Pharma Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Little Green Pharma's Net Cash per Share for the quarter that ended in Sep. 2023 was A$-0.02.

The historical rank and industry rank for Little Green Pharma's Net Cash per Share or its related term are showing as below:

During the past 4 years, the highest Price-to-Net-Cash Ratio of Little Green Pharma was 56.50. The lowest was 8.80. And the median was 19.83.

ASX:LGP's Price-to-Net-Cash is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.76
* Ranked among companies with meaningful Price-to-Net-Cash only.

Little Green Pharma Net Cash per Share Historical Data

The historical data trend for Little Green Pharma's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Little Green Pharma Net Cash per Share Chart

Little Green Pharma Annual Data

Trend

Jun19

Jun20

Jun21

Mar23

Net Cash per Share

0.06

0.10

-0.01

Little Green Pharma Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Mar23	Sep23
Net Cash per Share	Get a 7-Day Free Trial			0.01	0.10	0.03	-0.01	-0.02

Competitive Comparison of Little Green Pharma's Net Cash per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Little Green Pharma's Price-to-Net-Cash Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Little Green Pharma's Price-to-Net-Cash falls into.

Little Green Pharma Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Little Green Pharma's Net Cash per Share for the fiscal year that ended in Mar. 2023 is calculated as

	Net Cash per Share (A: Mar. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(12.4	-	16.391	-	0)	/	297.891
=	-0.01

Little Green Pharma's Net Cash per Share for the quarter that ended in Sep. 2023 is calculated as

	Net Cash per Share (Q: Sep. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(6.193	-	12.214	-	0)	/	300.093
=	-0.02

Little Green Pharma (ASX:LGP) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

Little Green Pharma Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Little Green Pharma's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Little Green Pharma (ASX:LGP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Little Green Pharma Ltd (ASX:LGP) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

66 Kings Park Road, Level 2, Suite 2, West Perth, Perth, WA, AUS, 6005

Website

https://www.littlegreenpharma.com

Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). The company offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

Little Green Pharma (ASX:LGP) Headlines

No Headlines